Mylotarg has potent anti-leukaemic effect: a systematic review and meta-analysis of anti-CD33 antibody treatment in acute myeloid leukaemiaJustin Loke, Keith Wheatley|Annals of Hematology|2014Cited by 69
Outcomes with single-agent gilteritinib for relapsed or refractory <i>FLT3</i>-mutant AML after contemporary induction therapyJad Othman, Richard Dillon, Maximillian H. Brodermann et al.|Blood Advances|2024Cited by 10